The ATCC MDAMB231 cell line is a critical tool in cancer research, particularly for studies focused on breast cancer. This cell line, derived from a patient with metastatic breast cancer, exhibits aggressive growth and is often used to investigate the mechanisms of cancer progression and metastasis. Researchers utilize the ATCC MDAMB231 line to test new therapeutic approaches and understand how breast cancer cells respond to various treatments.
Here are some key features of the ATCC MDAMB231 cell line:
- Proven quality: The ATCC MDAMB231 cell line is autcated and extensively characterized, ensuring reliable results in research.
- Customer-approved: This cell line is trusted by thousands of researchers globally for its consistency and reproducibility in experiments.
- Versatile applications: It is used in a variety of studies, including drug discovery, gene expression analysis, and cancer biology.
- Robust growth: The ATCC MDAMB231 cells are known for their rapid proliferation, making them ideal for high-throughput screening.
By utilizing the ATCC MDAMB231 cell line, researchers can gain valuable insights into breast cancer dynamics and develop more effective treatment strategies. Regular updates in research methodologies and findings related to this cell line ensure that it remains relevant in the ever-evolving field of cancer research.